Pfizer plans to ask U.S. to authorize booster dose, says top scientist

The vaccine company's chief scientific officer says that a third shot can generate a higher level of antibodies to protect individuals against COVID-19. Data found that over a six-month period, antibodies began to decrease in effectiveness, which the company attributes to people who were vaccinated early in the year.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting